Join
Live feed
·
PRReleasevia Quantisnow
Tenax Therapeutics Inc. logo

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

ByQuantisnow·Wall Street's wire, on your screen.
TENX· Tenax Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TENX (Tenax Therapeutics Inc.) and more on Quantisnow.